comparemela.com

Latest Breaking News On - Vaccine strategic committee - Page 1 : comparemela.com

Covid-19: Over 4,000 MAF health staff to be inoculated first

22 Feb 2021 / 17:54 H. Pix for illustration purposes. KUALA LUMPUR: More than 4,000 Malaysian Armed Forces (MAF) health staff are expected to be given priority to receive the Covid-19 Pfizer-BioNTech vaccine in the first phase of the national immunisation programme. Covid-19 Vaccine Strategic Committee acting chairman and Inspector General of MAF’s Health Services Division Brig Gen Datuk Dr Rosman Ab Rahman said 4,680 doses of the vaccine were received by MAF today. “The vaccination (for the health staff) will be done after Prime Minister Tan Sri Muhyiddin Yassin, who is scheduled to be inoculated this Wednesday. “We are still planning (about) who will receive the vaccine. (However), priority is given to MAF health staff, frontliners, and those working in red zones, while personnel working in key areas are also among those being considered for the time being,“ he said.

Four thousand MAF health staff to be inoculated first

Four thousand MAF health staff to be inoculated first February 22, 2021 KUALA LUMPUR – More than 4,000 Malaysian Armed Forces (MAF) health staff are expected to be given priority to receive the COVID-19 Pfizer-BioNTech vaccine in the first phase of the national immunisation programme. COVID-19 Vaccine Strategic Committee acting chairman and Inspector General of MAF’s Health Services Division Brig Gen Datuk Dr Rosman Ab Rahman said 4,680 doses of the vaccine were received by MAF today. Advertisement “The vaccination (for the health staff) will be done after Prime Minister Tan Sri Muhyiddin Yassin, who is scheduled to be inoculated this Wednesday. “We are still planning (about) who will receive the vaccine. (However), priority is given to MAF health staff, frontliners, and those working in red zones, while personnel working in key areas are also among those being considered for the time being,” he said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.